Pasar al contenido principal

DESREGULACION DE LA SINAPTOGENESIS POR EFECTO DEL PEPTIDO -AMILOIDE SOBRE LOS MECANORRECEPTORES TRPM7 Y PIEZO1 Y LA SEÑALIZACION DE CAMKIIA

PID2020-117691RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT POMPEU FABRA CCT

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A genome-wide functional screen identifies enhancer and protective genes for amyloid beta-peptide toxicity

  • Picón-Pagès, Pol
  • Bosch Morató, Mònica, 1986-
  • Subirana, Laia
  • Rubio-Moscardó, Francisca
  • Guivernau Almazán, Biuse, 1988-
  • Fanlo-Ucar, Hugo
  • Zeylan, Melisa Ece
  • Senyuz, Simge
  • Herrera-Fernández, Víctor
  • Vicente García, Rubén, 1978-
  • Fernández-Fernández, José Manuel, 1967-
  • García Ojalvo, Jordi
  • Gursoy, Attila
  • Keskin, Ozlem
  • Oliva Miguel, Baldomero
  • Posas Garriga, Francesc
  • Nadal Clanchet, Eulàlia de
  • Muñoz López, Francisco José, 1964-
Alzheimer's disease (AD) is known to be caused by amyloid β-peptide (Aβ) misfolded into β-sheets, but this knowledge has not yet led to treatments to prevent AD. To identify novel molecular players in Aβ toxicity, we carried out a genome-wide screen in Saccharomyces cerevisiae, using a library of 5154 gene knock-out strains expressing Aβ1-42. We identified 81 mammalian orthologue genes that enhance Aβ1-42 toxicity, while 157 were protective. Next, we performed interactome and text-mining studies to increase the number of genes and to identify the main cellular functions affected by Aβ oligomers (oAβ). We found that the most affected cellular functions were calcium regulation, protein translation and mitochondrial activity. We focused on SURF4, a protein that regulates the store-operated calcium channel (SOCE). An in vitro analysis using human neuroblastoma cells showed that SURF4 silencing induced higher intracellular calcium levels, while its overexpression decreased calcium entry. Furthermore, SURF4 silencing produced a significant reduction in cell death when cells were challenged with oAβ1-42, whereas SURF4 overexpression induced Aβ1-42 cytotoxicity. In summary, we identified new enhancer and protective activities for Aβ toxicity and showed that SURF4 contributes to oAβ1-42 neurotoxicity by decreasing SOCE activity., This work was supported by the Spanish Ministry of Science and Innovation and Agencia Estatal de Investigación plus European Regional Development Fund (FEDER Funds) through grants PID2020-117691RB-I00/AEI/10.13039/501100011033 (FJM), SAF2017-83372-R (FJM), PID2020-113203RB-I00 (BO), PID2021-127311NB-I00 (JGO), RTI2018-094809-B-I00 (JMF-F) and PID2019-106755RB-I00 (RV). The laboratories of FP and EdN are supported by a coordinated grant from the Ministry of Science, Innovation, and Universities (PID2021-124723NB-C21/C22 and FEDER) and the Government of Catalonia (2017 SGR 799). This work was also funded by the Spanish Institute of Health Carlos III by project reference AC20/00009-FEDER/UE and European Research Area Net (ERANET) ERA-CVD_JTC2020-015 (JGO), TÜBİTAK UPAG ERA-CVD 220N252 (AG), the “María de Maeztu Programme” for Units of Excellence in Research and Development (R&D; award CEX2018-000792-M) and Fundación QUAES through Cátedra QUAES-UPF de Biomedicina e Ingeniería Biomédica. We gratefully acknowledge institutional funding from the Ministry of Science, Innovation and Universities through the Centres of Excellence Severo Ochoa Award, and from the CERCA Programme of the Government of Catalonia. FP, EdN and JGO also acknowledge the support from the Institució Catalana de Recerca i Estudis Avançats (ICREA) Academia programme (Government of Catalonia).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The dual role of amyloid beta-peptide in oxidative stress and inflammation: Unveiling their connections in Alzheimer's disease etiopathology

  • Fanlo-Ucar, Hugo
  • Picón-Pagès, Pol
  • Herrera Fernández, Víctor
  • Ill-Raga, Gerard, 1982-
  • Muñoz López, Francisco José, 1964-
Alzheimer's disease (AD) is a progressive neurodegenerative disease, and it is currently the seventh leading cause of death worldwide. It is characterized by the extracellular aggregation of the amyloid β-peptide (Aβ) into oligomers and fibrils that cause synaptotoxicity and neuronal death. Aβ exhibits a dual role in promoting oxidative stress and inflammation. This review aims to unravel the intricate connection between these processes and their contribution to AD progression. The review delves into oxidative stress in AD, focusing on the involvement of metals, mitochondrial dysfunction, and biomolecule oxidation. The distinct yet overlapping concept of nitro-oxidative stress is also discussed, detailing the roles of nitric oxide, mitochondrial perturbations, and their cumulative impact on Aβ production and neurotoxicity. Inflammation is examined through astroglia and microglia function, elucidating their response to Aβ and their contribution to oxidative stress within the AD brain. The blood-brain barrier and oligodendrocytes are also considered in the context of AD pathophysiology. We also review current diagnostic methodologies and emerging therapeutic strategies aimed at mitigating oxidative stress and inflammation, thereby offering potential treatments for halting or slowing AD progression. This comprehensive synthesis underscores the pivotal role of Aβ in bridging oxidative stress and inflammation, advancing our understanding of AD and informing future research and treatment paradigms., This work was supported by the Spanish Ministry of Science, Innovation and Universities (MCIU) and the Agencia Estatal de Investigación (AEI) plus European Social Fund Plus (FSE+) through grant PID2020-117691RB-I00/AEI/10.13039/501100011033 and PID2023-149767OB-I00 with the reference MCIU/AEI/10.13039/501100011033 plus FSE+. This work was also funded by the “María de Maeztu Programme” for Units of Excellence in Research and Development (R&D; award CEX2018-000792-M).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Big dynorphin is a neuroprotector scaffold against amyloid β-peptide aggregation and cell toxicity

  • Gallego-Villarejo, Lucía
  • Wallin, Cecilia
  • Król, Sylwia
  • Enrich-Bengoa, Jennifer
  • Suades, Albert
  • Aguilella-Arzo, Marcel
  • Gomara, Maria J.
  • Haro, Isabel
  • Wärmlander, Sebastian
  • Muñoz López, Francisco José, 1964-
  • Gräslund, Astrid
  • Perálvarez Marín, Alex
Amyloid β-peptide (Aβ) misfolding into β-sheet structures triggers neurotoxicity inducing Alzheimer's disease (AD). Molecules able to reduce or to impair Aβ aggregation are highly relevant as possible AD treatments since they should protect against Aβ neurotoxicity. We have studied the effects of the interaction of dynorphins, a family of opioid neuropeptides, with Aβ40 the most abundant species of Aβ. Biophysical measurements indicate that Aβ40 interacts with Big Dynorphin (BigDyn), lowering the amount of hydrophobic aggregates, and slowing down the aggregation kinetics. As expected, we found that BigDyn protects against Aβ40 aggregates when studied in human neuroblastoma cells by cell survival assays. The cross-interaction between BigDyn and Aβ40 provides insight into the mechanism of amyloid pathophysiology and may open up new therapy possibilities., This work was supported by the Spanish Ministry of Science and Innovation and Agencia Estatal de Investigación through grant MCIN/AEI/ https://doi.org/10.13039/501100011033 (projects 2019-108434GB-I00 to M.A.-A., PID2020-117691RB-I00 to F.J.M., and PID2020-120222GB-I00 to A.P.-M.), Generalitat Valenciana (project AICO/2020/066 to M.A-A.), FEDER Funds and by the “María de Maeztu Programme” for Units of Excellence in R&D (award CEX2018-000792-M). A.G. was supported by grants from the Swedish Research Council.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Differential regulation of insulin signalling by monomeric and oligomeric amyloid beta-peptide

  • Molina Fernández, Rubén
  • Picón-Pagès, Pol
  • Barranco Almohalla, Alejandro
  • Crepin, Giulia
  • Herrera-Fernández, Víctor
  • Garcia-Elias Heras, Anna
  • Fanlo-Ucar, Hugo
  • Fernàndez Busquets, Xavier
  • García Ojalvo, Jordi
  • Oliva Miguel, Baldomero
  • Muñoz López, Francisco José, 1964-
Alzheimer's disease and Type 2 diabetes are pathological processes associated to ageing. Moreover, there are evidences supporting a mechanistic link between Alzheimer's disease and insulin resistance (one of the first hallmarks of Type 2 diabetes). Regarding Alzheimer's disease, amyloid β-peptide aggregation into β-sheets is the main hallmark of Alzheimer's disease. At monomeric state, amyloid β-peptide is not toxic but its function in brain, if any, is unknown. Here we show, by in silico study, that monomeric amyloid β-peptide 1-40 shares the tertiary structure with insulin and is thereby able to bind and activate insulin receptor. We validated this prediction experimentally by treating human neuroblastoma cells with increasing concentrations of monomeric amyloid β-peptide 1-40. Our results confirm that monomeric amyloid β-peptide 1-40 activates insulin receptor autophosphorylation, triggering downstream enzyme phosphorylations and the glucose Transporter 4 translocation to the membrane. On the other hand, neuronal insulin resistance is known to be associated to Alzheimer's disease since early stages. We thus modelled the docking of oligomeric amyloid β-peptide 1-40 to insulin receptor. We found that oligomeric amyloid β-peptide 1-40 blocks insulin receptor, impairing its activation. It was confirmed in vitro by observing the lack of insulin receptor autophosphorylation, and also the impairment of insulin-induced intracellular enzyme activations and the glucose Transporter 4 translocation to the membrane. By biological system analysis, we have carried out a mathematical model recapitulating the process that turns amyloid β-peptide binding to insulin receptor from the physiological to the pathophysiological regime. Our results suggest that monomeric amyloid β-peptide 1-40 contributes to mimic insulin effects in the brain, which could be good when neurons have an extra requirement of energy beside the well-known protective effects on insulin intracellular signalling, while its accumulation and subsequent oligomerization blocks the insulin receptor producing insulin resistance and compromising neuronal metabolism and protective pathways., This work was supported by the Spanish Ministry of Science and Innovation and Agencia Estatal de Investigación plus European Regional Development Fund (FEDER Funds) through grants PID2020-117691RB-I00/AEI/10.13039/501100011033 (F.J.M.), SAF2017-83372-R (F.J.M.), BIO2017-85329-R (B.O.), PGC2018-101251-B-I00 (J.G.-O.) and RTI2018-094579-B-I00 (X.F.-B.). This work was also funded by the Spanish Institute of Health Carlos III by project reference AC20/00009 -FEDER/UE and European Research Era Net (ERANET) ERA-CVD_JTC2020-015 (J.G.-O.), by the ‘María de Maeztu Programme’ for Units of Excellence in Research and Development (R&D; award CEX2018-000792-M), Generalitat de Catalunya (Spain) through the grant 2017-SGR-908 (X.F.-B.) and Fundación QUAES through Cátedra QUAES-UPF de Biomedicina e Ingeniería Biomédica. The Instituto de Salud Global de Barcelona (ISGlobal) and Institute for Bioengineering of Catalonia (IBEC) are members of the Centres de Recerca de Catalunya (CERCA) Programme, Generalitat de Catalunya (Spain). We acknowledge support from the Spanish Ministry of Science, Innovation and Universities through the ‘Centro de Excelencia Severo Ochoa 2019–2023’ Programme (CEX2018-000806-S). This research is part of ISGlobal's Programme on the Molecular Mechanisms of Malaria, which is partially supported by the Fundación Ramón Areces. J.G.-O. also acknowledges support from the Institució Catalana de Recerca i Estudis Avançats (ICREA) Academia programme.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Amyloid β-peptide causes the permanent activation of CaMKIIα through its oxidation

  • Picón-Pagès, Pol
  • Fanlo-Ucar, Hugo
  • Herrera-Fernández, Víctor
  • Ausellé Bosch, Sira
  • Galera López, Lorena, 1993-
  • Gutiérrez, Daniela A.
  • Ozaita Mintegui, Andrés, 1969-
  • Álvarez, Alejandra R.
  • Oliva Miguel, Baldomero
  • Muñoz López, Francisco José, 1964-
Alzheimer's disease (AD) is characterised by the presence of extracellular amyloid plaques in the brain. They are composed of aggregated amyloid beta-peptide (Aβ) misfolded into beta-sheets which are the cause of the AD memory impairment and dementia. Memory depends on the hippocampal formation and maintenance of synapses by long-term potentiation (LTP), whose main steps are the activation of NMDA receptors, the phosphorylation of CaMKIIα and the nuclear translocation of the transcription factor CREB. It is known that Aβ oligomers (oAβ) induce synaptic loss and impair the formation of new synapses. Here, we have studied the effects of oAβ on CaMKIIα. We found that oAβ produce reactive oxygen species (ROS), that induce CaMKIIα oxidation in human neuroblastoma cells as we assayed by western blot and immunofluorescence. Moreover, this oxidized isoform is significantly present in brain samples from AD patients. We found that the oxidized CaMKIIα is active independently of the binding to calcium/calmodulin, and that CaMKIIα phosphorylation is mutually exclusive with CaMKIIα oxidation as revealed by immunoprecipitation and western blot. An in silico modelling of the enzyme was also performed to demonstrate that oxidation induces an activated state of CaMKIIα. In brains from AD transgenic models of mice and in primary cultures of murine hippocampal neurons, we demonstrated that the oxidation of CaMKIIα induces the phosphorylation of CREB and its translocation to the nucleus to promote the transcription of ARC and BDNF. Our data suggests that CaMKIIα oxidation would be a pro-survival mechanism that is triggered when a noxious stimulus challenges neurons as do oAβ., This work was supported by the Spanish Ministry of Science and Innovation and Agencia Estatal de Investigación plus FEDER Funds through grants PID2020-117691RB-I00/AEI/10.13039/501100011033 (F.J.M.), SAF2017-83372-R (F.J.M.), BIO 2020-113203RB (B.O.) and PID2021-123482OB-I00 (A.O.). This work was also funded by the “María de Maetzu Programme” for Units of Excellence in R&D and the MM-MELIS intercollaborative projects (award CEX2018-000792-M/IPEP-MM2020-5). Funding for this project was also from the Comisión Nacional de Investigación Científica y Tecnológica-Chile: Fondecyt 12011668 (to A.R.Á.) and Millennium Science Initiative Program—ICN09_016/ICN 2021_045 (to A.R.Á.).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Big dynorphin is a neuroprotector scaffold against amyloid β-peptide aggregation and cell toxicity

  • Gallego-Villarejo, Lucía
  • Wallin, Cecilia
  • Król, Sylwia
  • Enrich-Bengoa, Jennifer
  • Suades, Albert
  • Aguilella-Arzo, Marcel
  • Gomara, Maria J.
  • Haro, Isabel
  • Wärmlander, Sebastian
  • Muñoz López, Francisco José, 1964-
  • Gräslund, Astrid
  • Perálvarez Marín, Alex
Amyloid β-peptide (Aβ) misfolding into β-sheet structures triggers neurotoxicity inducing Alzheimer's disease (AD). Molecules able to reduce or to impair Aβ aggregation are highly relevant as possible AD treatments since they should protect against Aβ neurotoxicity. We have studied the effects of the interaction of dynorphins, a family of opioid neuropeptides, with Aβ40 the most abundant species of Aβ. Biophysical measurements indicate that Aβ40 interacts with Big Dynorphin (BigDyn), lowering the amount of hydrophobic aggregates, and slowing down the aggregation kinetics. As expected, we found that BigDyn protects against Aβ40 aggregates when studied in human neuroblastoma cells by cell survival assays. The cross-interaction between BigDyn and Aβ40 provides insight into the mechanism of amyloid pathophysiology and may open up new therapy possibilities., This work was supported by the Spanish Ministry of Science and Innovation and Agencia Estatal de Investigación through grant MCIN/AEI/ https://doi.org/10.13039/501100011033 (projects 2019-108434GB-I00 to M.A.-A., PID2020-117691RB-I00 to F.J.M., and PID2020-120222GB-I00 to A.P.-M.), Generalitat Valenciana (project AICO/2020/066 to M.A-A.), FEDER Funds and by the “María de Maeztu Programme” for Units of Excellence in R&D (award CEX2018-000792-M). A.G. was supported by grants from the Swedish Research Council.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A genome-wide functional screen identifies enhancer and protective genes for amyloid beta-peptide toxicity

  • Picón-Pagès, Pol
  • Bosch Morató, Mònica, 1986-
  • Subirana, Laia
  • Rubio-Moscardó, Francisca
  • Guivernau Almazán, Biuse, 1988-
  • Fanlo-Ucar, Hugo
  • Zeylan, Melisa Ece
  • Senyuz, Simge
  • Herrera-Fernández, Víctor
  • Vicente García, Rubén, 1978-
  • Fernández-Fernández, José Manuel, 1967-
  • García Ojalvo, Jordi
  • Gursoy, Attila
  • Keskin, Ozlem
  • Oliva Miguel, Baldomero
  • Posas Garriga, Francesc
  • Nadal Clanchet, Eulàlia de
  • Muñoz López, Francisco José, 1964-
Alzheimer's disease (AD) is known to be caused by amyloid β-peptide (Aβ) misfolded into β-sheets, but this knowledge has not yet led to treatments to prevent AD. To identify novel molecular players in Aβ toxicity, we carried out a genome-wide screen in Saccharomyces cerevisiae, using a library of 5154 gene knock-out strains expressing Aβ1-42. We identified 81 mammalian orthologue genes that enhance Aβ1-42 toxicity, while 157 were protective. Next, we performed interactome and text-mining studies to increase the number of genes and to identify the main cellular functions affected by Aβ oligomers (oAβ). We found that the most affected cellular functions were calcium regulation, protein translation and mitochondrial activity. We focused on SURF4, a protein that regulates the store-operated calcium channel (SOCE). An in vitro analysis using human neuroblastoma cells showed that SURF4 silencing induced higher intracellular calcium levels, while its overexpression decreased calcium entry. Furthermore, SURF4 silencing produced a significant reduction in cell death when cells were challenged with oAβ1-42, whereas SURF4 overexpression induced Aβ1-42 cytotoxicity. In summary, we identified new enhancer and protective activities for Aβ toxicity and showed that SURF4 contributes to oAβ1-42 neurotoxicity by decreasing SOCE activity., This work was supported by the Spanish Ministry of Science and Innovation and Agencia Estatal de Investigación plus European Regional Development Fund (FEDER Funds) through grants PID2020-117691RB-I00/AEI/10.13039/501100011033 (FJM), SAF2017-83372-R (FJM), PID2020-113203RB-I00 (BO), PID2021-127311NB-I00 (JGO), RTI2018-094809-B-I00 (JMF-F) and PID2019-106755RB-I00 (RV). The laboratories of FP and EdN are supported by a coordinated grant from the Ministry of Science, Innovation, and Universities (PID2021-124723NB-C21/C22 and FEDER) and the Government of Catalonia (2017 SGR 799). This work was also funded by the Spanish Institute of Health Carlos III by project reference AC20/00009-FEDER/UE and European Research Area Net (ERANET) ERA-CVD_JTC2020-015 (JGO), TÜBİTAK UPAG ERA-CVD 220N252 (AG), the “María de Maeztu Programme” for Units of Excellence in Research and Development (R&D; award CEX2018-000792-M) and Fundación QUAES through Cátedra QUAES-UPF de Biomedicina e Ingeniería Biomédica. We gratefully acknowledge institutional funding from the Ministry of Science, Innovation and Universities through the Centres of Excellence Severo Ochoa Award, and from the CERCA Programme of the Government of Catalonia. FP, EdN and JGO also acknowledge the support from the Institució Catalana de Recerca i Estudis Avançats (ICREA) Academia programme (Government of Catalonia).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Amyloid β-peptide causes the permanent activation of CaMKIIα through its oxidation

  • Picón-Pagès, Pol
  • Fanlo-Ucar, Hugo
  • Herrera-Fernández, Víctor
  • Ausellé Bosch, Sira
  • Galera López, Lorena, 1993-
  • Gutiérrez, Daniela A.
  • Ozaita Mintegui, Andrés, 1969-
  • Álvarez, Alejandra R.
  • Oliva Miguel, Baldomero
  • Muñoz López, Francisco José, 1964-
Alzheimer's disease (AD) is characterised by the presence of extracellular amyloid plaques in the brain. They are composed of aggregated amyloid beta-peptide (Aβ) misfolded into beta-sheets which are the cause of the AD memory impairment and dementia. Memory depends on the hippocampal formation and maintenance of synapses by long-term potentiation (LTP), whose main steps are the activation of NMDA receptors, the phosphorylation of CaMKIIα and the nuclear translocation of the transcription factor CREB. It is known that Aβ oligomers (oAβ) induce synaptic loss and impair the formation of new synapses. Here, we have studied the effects of oAβ on CaMKIIα. We found that oAβ produce reactive oxygen species (ROS), that induce CaMKIIα oxidation in human neuroblastoma cells as we assayed by western blot and immunofluorescence. Moreover, this oxidized isoform is significantly present in brain samples from AD patients. We found that the oxidized CaMKIIα is active independently of the binding to calcium/calmodulin, and that CaMKIIα phosphorylation is mutually exclusive with CaMKIIα oxidation as revealed by immunoprecipitation and western blot. An in silico modelling of the enzyme was also performed to demonstrate that oxidation induces an activated state of CaMKIIα. In brains from AD transgenic models of mice and in primary cultures of murine hippocampal neurons, we demonstrated that the oxidation of CaMKIIα induces the phosphorylation of CREB and its translocation to the nucleus to promote the transcription of ARC and BDNF. Our data suggests that CaMKIIα oxidation would be a pro-survival mechanism that is triggered when a noxious stimulus challenges neurons as do oAβ., This work was supported by the Spanish Ministry of Science and Innovation and Agencia Estatal de Investigación plus FEDER Funds through grants PID2020-117691RB-I00/AEI/10.13039/501100011033 (F.J.M.), SAF2017-83372-R (F.J.M.), BIO 2020-113203RB (B.O.) and PID2021-123482OB-I00 (A.O.). This work was also funded by the “María de Maetzu Programme” for Units of Excellence in R&D and the MM-MELIS intercollaborative projects (award CEX2018-000792-M/IPEP-MM2020-5). Funding for this project was also from the Comisión Nacional de Investigación Científica y Tecnológica-Chile: Fondecyt 12011668 (to A.R.Á.) and Millennium Science Initiative Program—ICN09_016/ICN 2021_045 (to A.R.Á.).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Differential regulation of insulin signalling by monomeric and oligomeric amyloid beta-peptide

  • Molina Fernández, Rubén
  • Picón-Pagès, Pol
  • Barranco Almohalla, Alejandro
  • Crepin, Giulia
  • Herrera-Fernández, Víctor
  • Garcia-Elias Heras, Anna
  • Fanlo-Ucar, Hugo
  • Fernàndez Busquets, Xavier
  • García Ojalvo, Jordi
  • Oliva Miguel, Baldomero
  • Muñoz López, Francisco José, 1964-
Alzheimer's disease and Type 2 diabetes are pathological processes associated to ageing. Moreover, there are evidences supporting a mechanistic link between Alzheimer's disease and insulin resistance (one of the first hallmarks of Type 2 diabetes). Regarding Alzheimer's disease, amyloid β-peptide aggregation into β-sheets is the main hallmark of Alzheimer's disease. At monomeric state, amyloid β-peptide is not toxic but its function in brain, if any, is unknown. Here we show, by in silico study, that monomeric amyloid β-peptide 1-40 shares the tertiary structure with insulin and is thereby able to bind and activate insulin receptor. We validated this prediction experimentally by treating human neuroblastoma cells with increasing concentrations of monomeric amyloid β-peptide 1-40. Our results confirm that monomeric amyloid β-peptide 1-40 activates insulin receptor autophosphorylation, triggering downstream enzyme phosphorylations and the glucose Transporter 4 translocation to the membrane. On the other hand, neuronal insulin resistance is known to be associated to Alzheimer's disease since early stages. We thus modelled the docking of oligomeric amyloid β-peptide 1-40 to insulin receptor. We found that oligomeric amyloid β-peptide 1-40 blocks insulin receptor, impairing its activation. It was confirmed in vitro by observing the lack of insulin receptor autophosphorylation, and also the impairment of insulin-induced intracellular enzyme activations and the glucose Transporter 4 translocation to the membrane. By biological system analysis, we have carried out a mathematical model recapitulating the process that turns amyloid β-peptide binding to insulin receptor from the physiological to the pathophysiological regime. Our results suggest that monomeric amyloid β-peptide 1-40 contributes to mimic insulin effects in the brain, which could be good when neurons have an extra requirement of energy beside the well-known protective effects on insulin intracellular signalling, while its accumulation and subsequent oligomerization blocks the insulin receptor producing insulin resistance and compromising neuronal metabolism and protective pathways., This work was supported by the Spanish Ministry of Science and Innovation and Agencia Estatal de Investigación plus European Regional Development Fund (FEDER Funds) through grants PID2020-117691RB-I00/AEI/10.13039/501100011033 (F.J.M.), SAF2017-83372-R (F.J.M.), BIO2017-85329-R (B.O.), PGC2018-101251-B-I00 (J.G.-O.) and RTI2018-094579-B-I00 (X.F.-B.). This work was also funded by the Spanish Institute of Health Carlos III by project reference AC20/00009 -FEDER/UE and European Research Era Net (ERANET) ERA-CVD_JTC2020-015 (J.G.-O.), by the ‘María de Maeztu Programme’ for Units of Excellence in Research and Development (R&D; award CEX2018-000792-M), Generalitat de Catalunya (Spain) through the grant 2017-SGR-908 (X.F.-B.) and Fundación QUAES through Cátedra QUAES-UPF de Biomedicina e Ingeniería Biomédica. The Instituto de Salud Global de Barcelona (ISGlobal) and Institute for Bioengineering of Catalonia (IBEC) are members of the Centres de Recerca de Catalunya (CERCA) Programme, Generalitat de Catalunya (Spain). We acknowledge support from the Spanish Ministry of Science, Innovation and Universities through the ‘Centro de Excelencia Severo Ochoa 2019–2023’ Programme (CEX2018-000806-S). This research is part of ISGlobal's Programme on the Molecular Mechanisms of Malaria, which is partially supported by the Fundación Ramón Areces. J.G.-O. also acknowledges support from the Institució Catalana de Recerca i Estudis Avançats (ICREA) Academia programme.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The dual role of amyloid beta-peptide in oxidative stress and inflammation: Unveiling their connections in Alzheimer's disease etiopathology

  • Fanlo-Ucar, Hugo
  • Picón-Pagès, Pol
  • Herrera Fernández, Víctor
  • Ill-Raga, Gerard, 1982-
  • Muñoz López, Francisco José, 1964-
Alzheimer's disease (AD) is a progressive neurodegenerative disease, and it is currently the seventh leading cause of death worldwide. It is characterized by the extracellular aggregation of the amyloid β-peptide (Aβ) into oligomers and fibrils that cause synaptotoxicity and neuronal death. Aβ exhibits a dual role in promoting oxidative stress and inflammation. This review aims to unravel the intricate connection between these processes and their contribution to AD progression. The review delves into oxidative stress in AD, focusing on the involvement of metals, mitochondrial dysfunction, and biomolecule oxidation. The distinct yet overlapping concept of nitro-oxidative stress is also discussed, detailing the roles of nitric oxide, mitochondrial perturbations, and their cumulative impact on Aβ production and neurotoxicity. Inflammation is examined through astroglia and microglia function, elucidating their response to Aβ and their contribution to oxidative stress within the AD brain. The blood-brain barrier and oligodendrocytes are also considered in the context of AD pathophysiology. We also review current diagnostic methodologies and emerging therapeutic strategies aimed at mitigating oxidative stress and inflammation, thereby offering potential treatments for halting or slowing AD progression. This comprehensive synthesis underscores the pivotal role of Aβ in bridging oxidative stress and inflammation, advancing our understanding of AD and informing future research and treatment paradigms., This work was supported by the Spanish Ministry of Science, Innovation and Universities (MCIU) and the Agencia Estatal de Investigación (AEI) plus European Social Fund Plus (FSE+) through grant PID2020-117691RB-I00/AEI/10.13039/501100011033 and PID2023-149767OB-I00 with the reference MCIU/AEI/10.13039/501100011033 plus FSE+. This work was also funded by the “María de Maeztu Programme” for Units of Excellence in Research and Development (R&D; award CEX2018-000792-M).